T. Fulop et I. Seres, AGE-RELATED-CHANGES IN SIGNAL-TRANSDUCTION - IMPLICATIONS FOR NEURONAL TRANSMISSION AND POTENTIAL FOR DRUG INTERVENTION, Drugs & aging, 5(5), 1994, pp. 366-390
Problems associated with aging will become one of the leading health d
ilemmas of the next century. Age-associated diseases, including those
affecting the neuronal system, are increasing in frequency. Age-relate
d deficiencies in the brain result in impaired motor functions, sleep,
behaviour and cognitive functions. Good functioning of the brain is b
ased on the communication between neurons, by means of signal sending
and processing. Neuronal transmission is a very complex phenomenon whi
ch involves neuromediator receptors, ion channels and various signal t
ransduction systems. Aging is associated with modification of many bra
in neurotransmitter and second messenger systems directly involved in
signal transduction. Thus, signal transduction events that are deficie
nt in the aged include calcium mobilisation, phosphatidylinositol brea
kdown, cyclic nucleotides formation, accumulation of proto-oncogene tr
anscripts and synthesis of new proteins, such as certain neurotransmit
ters. Other events in signal transduction, such as protein tyrosine ki
nase activity, G-protein structure and function and receptor-G-protein
coupling, have not been studied in great detail as yet. Alterations i
n these various intracellular signalling events may fundamentally infl
uence the functional activity of neurons, and, in consequence, play an
important role in the age-dependent alterations of brain functions. F
uture studies are needed to better understand the molecular basis and
the importance of signal transduction changes with aging. Such knowled
ge will certainly lead to design of better drugs for the prevention or
treatment of age-related deficiencies or diseases, such as Parkinson'
s disease or Alzheimer's disease.